centers for disease control and prevention

CLAAD Highlights 5 Technologies to Reduce Prescription Drug Abuse

CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse

Filed under: drug addiction help centers

"We are proud to recognize the Top 5 honorees joining Millennium in the critically important effort to advance patient care and help address the epidemic… Continue reading

Benita Terrell, Student and Peer Counselor, Reveals What HIV Looks Like

Benita Terrell, Student And Peer Counselor, Reveals What HIV Looks Like

Filed under: drug treatment centers in pa

More than half of HIV-infected young people are <a href="http://www.huffingtonpost.com/2012/11/27/hiv-youths-infected-aids-young-people_n_2198629.html">unaware that they have the virus</a>, according to a Centers for Disease Control… Continue reading

INCYTE CORPORATION : New Data for Jakafi® (Ruxolitinib) to Be Presented at

INCYTE CORPORATION : New Data for Jakafi® (ruxolitinib) to Be Presented at

Filed under: drug treatment centers in georgia

8 to 11 at the Georgia World Congress Center in Atlanta. Jakafi, an oral Janus kinase (JAK) inhibitor, is FDA-approved… Continue reading

Medical Marijuana Is Legal in 18 States, but It's Clear We've Only Discovered

Medical marijuana is legal in 18 states, but it's clear we've only discovered

Filed under: Drug Treatment Centers District of Columbia

Could pot stop breast cancer? (Credit: Reuters/Cliff Despeaux). This article originally appeared on AlterNet. AlterNet There are now… Continue reading

Bill O'Reilly on 'Gangnam Style': 'What'S Going On???' (VIDEO)

Bill O'Reilly On 'Gangnam Style': 'What's Going On???' (VIDEO)

Filed under: Drug Abuse District of Columbia

WASHINGTON – JANUARY 08: FOX News host Shepard Smith poses on the red carpet upon arrival at a salute to FOX News Channel's Brit… Continue reading

Direct Anti-HCV Drugs Show Good Response in Routine Practice

Direct Anti-HCV Drugs Show Good Response in Routine Practice

Filed under: drug treatment programs maryland

"The end-of-treatment response rates basically look the same [for boceprevir and telaprevir] in any of the subgroups we looked at," lead researcher Lisa Backus, MD,… Continue reading